Important FLU Notice For Providers
As you are aware, the nation and New York State are witnessing a major increase in the number of influenza cases and hospitalizations for this season. As a result, the need to promote flu vaccination and the expedient use of antiviral medication (Tamiflu) for both prophylaxis and treatment of the flu is paramount. Given the recent shortage of generic Tamiflu, all restrictions and prior authorization protocols for brand Tamiflu will be lifted at the end of business tomorrow, February 2, 2018. In addition , it should be noted that although Tamiflu is best initiated within 48 hours of flu symptom onset, the medication has been shown to have benefit when started after 48 hours.
Given the serious concerns of an influenza breakout in an inpatient facility, the need for quick access to a supply of antiviral medication must be addressed. Please reference the attached links regarding CDC guidance for outbreaks in LTC facilities https://www.cdc.gov/flu/professionals/infectioncontrol/ltc-facility-guidance.htm and information on antiviral drug supply https://www.cdc.gov/flu/antivirals/supply.htm.
In addition to the above, the CDC Health Advisory document addressing influenza activity and antiviral treatment for influenza. Click here for your review.
Thank you for your immediate attention to this matter.
John V. Dellosso, MD, FACP
Senior Medical Director, VillageCareMAX